Baird Medical Investment Holdings Limited
NASDAQ:BDMDMedical - Devices
-$0.09 today
- Market cap
- $50.65M
- Beta
- -1.23
- P/E (TTM)
- -1.3
- EPS (TTM)
- -$0.94
Volume 0.02M
Average 0.37M
BDMD Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Baird Medical Investment Holdings LimitedNASDAQ: BDMD
Net Receivables · Q4 FY2025 · quarter ended Dec 2025
Net receivables falls 8.7% from a year ago
Net receivables stood at $42.53M at the end of Q4 FY2025, down 8.7% from a year earlier. Over 3 fiscal years it compounded at +19.8% a year.
Context
- Net receivables amounted to 61.0% of total assets at the end of Q4 FY2025, up 1.3 pp from a year earlier.
- Net receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -8.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 42.53M USD
- Year-over-year change
- -8.7%
- 4-year CAGR
- +36.0%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 42.53M | -8.7% |
| FY2024 | 2024-12-31 | 46.58M | +47.9% |
| FY2023 | 2023-12-31 | 31.49M | +27.2% |
| FY2022 | 2022-12-31 | 24.76M | +98.9% |
| FY2021 | 2021-12-31 | 12.45M | — |
Net Receivables vs competitors
How BDMD compares with its peers on the latest reported figures
- BDMD's Dec 2025 net receivables of $42.53M is the highest of the 4 companies compared; the peer median is $872K.
- Its year-over-year change of -8.7% is the 2nd highest of 3, against a peer median of -7.9%.
- Net receivables amounts to 61.0% of total assets for BDMD, versus a peer median of 5.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
BDMDBaird Medical Investment Holdings Limited | Dec 2025 | $42.53M | -8.7% | +19.8% | 61.0% |
| Mar 2026 | $9.5M | +24.4% | +21.3% | 10.0% | |
| Mar 2026 | $872K | -40.2% | +36.8% | 5.6% | |
OKUROnKure Therapeutics, Inc. | Mar 2026 | $0 | — | — | 0.0% |
| Peer median (excluding BDMD) | $872K | -7.9% | +29.1% | 5.6% | |
Competitors are the stored peer set for BDMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3.03M | 1.71M | 1.51M | 2.97M | 178.32K |
| Short-term Investments | 407.5K | 197K | 120.49K | 0 | 0 |
| Net Receivables | 12.45M | 24.76M | 31.49M | 46.58M | 42.53M |
| Inventory | 3.06M | 1.29M | 1.14M | 1.3M | 1.09M |
| Other Current Assets | 304.29K | 197K | 120.49K | 295.75K | 628.04K |
| Total Current Assets | 22.4M | 33.76M | 40.08M | 61.42M | 54.97M |
| Property, Plant & Equipment (Net) | 3.33M | 2.73M | 7M | 7.62M | 6.55M |
| Goodwill | 66.17K | 61.14K | 59.38K | 57.77K | 60.3K |
| Intangible Assets | 62.77K | 49.48K | 25.48K | 16.53K | 8.63K |
| Long-term Investments | (108.15K) | (206.22K) | (814.37K) | 0 | 0 |
| Tax Assets | 79.78K | 206.22K | 1.63M | 714.46K | 762.29K |
| Other Non-current Assets | 190.08K | 5.81M | 10.36M | 8.14M | 7.35M |
| Total Non-current Assets | 3.72M | 8.85M | 16.63M | 16.55M | 14.73M |
| Total Assets | 26.12M | 42.62M | 56.71M | 77.96M | 69.7M |
| Account Payables | 340.21K | 215.86K | 550.19K | 1.25M | 1.81M |
| Short-term Debt | 2.04M | 6.23M | 8.17M | 17.03M | 13.07M |
| Tax Payables | 739.4K | 1.8M | 770.95K | 2.87M | 3.1M |
| Deferred Revenue | 701.53K | 692.51K | 499.91K | 792.1K | 793.41K |
| Other Current Liabilities | 29.91K | 20.32K | 93.39K | 45.24K | 8.76K |
| Total Current Liabilities | 9.77M | 16.02M | 18.98M | 34.62M | 32.36M |
| Long-term Debt | 0 | 0 | 0 | 3.44M | 6.09M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 1.61M | 0 | 0 |
| Total Non-current Liabilities | 494.12K | 816.88K | 2.03M | 3.58M | 6.11M |
| Total Liabilities | 10.26M | 16.84M | 21M | 38.2M | 38.48M |
| Common Stock | 11.64K | 2.94K | 2.94K | 2.56K | 3.08K |
| Retained Earnings | (7.13M) | 3.96M | 14.39M | 26.76M | (515.42K) |
| Accumulated OCI | 3.31M | 3.12M | 2.5M | 1.45M | 3.22M |
| Other Stockholders Equity | (9.84M) | 0 | 0 | 0 | 0 |
| Minority Interest | (356.73K) | (155.59K) | (43.39K) | 101.34K | (144.09K) |
| Total Equity | 4.85M | 25.78M | 35.71M | 39.76M | 31.22M |
| Total Debt | 2.93M | 7.44M | 9.9M | 20.88M | 19.3M |
| Net Debt | (97.6K) | 5.73M | 8.39M | 17.91M | 19.12M |
Baird Medical Investment Holdings Limited
NASDAQ:BDMD
Intrinsic Alpha fair value
Locked
Current Price
$1.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.